Please login to the form below

Not currently logged in

tax inversion

This page shows the latest tax inversion news and features for those working in and with pharma, biotech and healthcare.

Shire rebuffs Takeda bids, as Allergan bows out

Shire rebuffs Takeda bids, as Allergan bows out

AbbVie offered $55bn for the biopharma in 2014, but the transaction was abandoned after the US introduced new measures to discourage tax inversion deals.

Latest news

More from news
Approximately 7 fully matching, plus 40 partially matching documents found.

Latest Intelligence

  • 2016: The year when deal-makers took stock? 2016: The year when deal-makers took stock?

    curb tax inversion s.

  • A rare talent A rare talent

    took steps to prevent 'tax inversion' mergers.

  • Deal Watch October 2016 Deal Watch October 2016

    years because of the taxman's changes in tax inversion rules.

  • Deal Watch August 2016 Deal Watch August 2016

    In April this year the major news was the collapse of Pfizer's $160bn acquisition of Allergan as a result of change in US tax regulations to prevent tax inversions. ... This can turn into a hostile bid. For example, Pfizer made an unsolicited bid for

  • Deal Watch April 2016 Deal Watch April 2016

    Pfizer's dogged determination to achieve a tax inversion can only be described as a fiasco and given, that this was the second time of trying, perhaps fiascos, is more appropriate. ... Non US countries where Pfizer have parked $80bn. Non-US target

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....